Trading Ideas Moderna, Inc.

Equities

MRNA

US60770K1079

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-14 pm EST			5-day change	1st Jan Change
34.46 ^USD	-1.96%		-27.50%	-17.12%

12:22pm	Morgan Stanley Cuts Price Target on Moderna to $38 From $70, Keeps Equalweight Rating	MT
11:12am	Analyst recommendations: Adobe, Intuit, XPO, Netflix, Tesla...

Trading Ideas

MODERNA, INC.: A support level that should be taken advantage of	22-03-09
MODERNA, INC.: The beginning of the move	20-11-20
MODERNA, INC.: Technically solid	20-09-28
MODERNA, INC.: The underlying trend is to the upside	20-08-25
MODERNA, INC.: There is still some upside potential	20-08-04
MODERNA, INC.: Buying pressure	20-07-13
MODERNA, INC.: The underlying trend is to the upside	20-05-20

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Moderna, Inc. prepares for the post-Covid era

Moderna, Inc. prepares for the post-Covid era

March 25, 2024 at 10:24 am EDT

Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector

January 16, 2024 at 03:31 pm EST

Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector